ConductScience.org, home

Paper20011245

The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab.

Kelly R and 3 others. Ther Clin Risk Manag, 2009. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab. Papers, record 20011245. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20011245

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab.
PubMed
Journal
Ther Clin Risk Manag
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.93
iCite
Revised in PubMed
2021-10-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kelly RRichard
2Richards SStephen
3Hillmen PPeter
4Hill AAnita

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111703352Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia.Br J Haematol2001https://conductscience.org/library/papers/11703352PubMed
212424196The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot.Blood2003https://conductscience.org/library/papers/12424196PubMed
35935361Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.J Clin Invest1966https://conductscience.org/library/papers/5935361PubMed
49238050Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9238050PubMed
515230287Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus.Lupus2004https://conductscience.org/library/papers/15230287PubMed
61312369The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria.Blood1992https://conductscience.org/library/papers/1312369PubMed
716195329Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP.Blood2006https://conductscience.org/library/papers/16195329PubMed
815507422The kidney in paroxysmal nocturnal haemoglobinuria: MRI findings.Br J Radiol2004https://conductscience.org/library/papers/15507422PubMed
912627844Molecular genetics of paroxysmal nocturnal hemoglobinuria.Int J Hematol2003https://conductscience.org/library/papers/12627844PubMed
1018952283Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab.Leuk Res2009https://conductscience.org/library/papers/18952283PubMed
1110220445Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10220445PubMed
128630422Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria.Blood1996https://conductscience.org/library/papers/8630422PubMed
1318549907Warfarin-induced bleeding complications - clinical presentation and therapeutic options.Thromb Res2008https://conductscience.org/library/papers/18549907PubMed
1410629597The molecular basis of paroxysmal nocturnal hemoglobinuria.Haematologica2000https://conductscience.org/library/papers/10629597PubMed
159171898Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.Mol Immunol1996https://conductscience.org/library/papers/9171898PubMed
1616051736Diagnosis and management of paroxysmal nocturnal hemoglobinuria.Blood2005https://conductscience.org/library/papers/16051736PubMed
1715985537Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria.Blood2005https://conductscience.org/library/papers/15985537PubMed
1812149196Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.Blood2002https://conductscience.org/library/papers/12149196PubMed
1917702897Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.Blood2007https://conductscience.org/library/papers/17702897PubMed
2017408457Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria.Br J Haematol2007https://conductscience.org/library/papers/17408457PubMed

See all 63 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
42836124Integrating paroxysmal nocturnal hemoglobinuria (PNH) into mainstream hematological curriculum training.Hemasphere2026https://conductscience.org/library/papers/42836124PubMed
41280269Diffuse Large B-Cell Lymphoma Combined With Paroxysmal Nocturnal Hemoglobinuria: A Rare Case Report.Clin Case Rep2025https://conductscience.org/library/papers/41280269PubMed
41002734Paroxysmal Nocturnal Hemoglobinuria: Unraveling Its Molecular Pathogenesis and Advancing Targeted Therapeutic Strategies.Diseases2025https://conductscience.org/library/papers/41002734PubMed
40777953The Onerous task of managing paroxysmal nocturnal hemoglobinuria in a Low resource setting: a case report. A hematologist's experience.Afr Health Sci2024https://conductscience.org/library/papers/40777953PubMed
40655402Real-World effectiveness of eculizumab in atypical hemolytic uremic syndrome: a retrospective study from Western China.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40655402PubMed
40560515Model-Informed Precision Dosing of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria.Clin Pharmacokinet2025https://conductscience.org/library/papers/40560515PubMed
37494350Characteristics of paroxysmal nocturnal hemoglobinuria patients in Brazil: A retrospective administrative claims database analysis of PNH patients in Brazilian public healthcare system.PLoS One2023https://conductscience.org/library/papers/37494350PubMed
37180495A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?Ther Adv Rare Dis2020https://conductscience.org/library/papers/37180495PubMed
32519233Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria.Pharmacoeconomics2020https://conductscience.org/library/papers/32519233PubMed
28808592A Case of Fulminant Meningococcemia: It Is All in the Complement.Case Rep Infect Dis2017https://conductscience.org/library/papers/28808592PubMed
28246555Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide.Ther Adv Hematol2017https://conductscience.org/library/papers/28246555PubMed
27964705Biological Drugs in Guillain-Barré Syndrome: An Update.Curr Neuropharmacol2017https://conductscience.org/library/papers/27964705PubMed
27570707Pesg PNH diagnosis, follow-up and treatment guidelines.Am J Blood Res2016https://conductscience.org/library/papers/27570707PubMed
27525082Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature.Clin Case Rep2016https://conductscience.org/library/papers/27525082PubMed
26742189A Hispanic female patient with heartburn: A rare presentation of Paroxysmal Nocturnal Hemoglobinuria.Bol Asoc Med P R2015https://conductscience.org/library/papers/26742189PubMed
26487933Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria.Hematol Rep2015https://conductscience.org/library/papers/26487933PubMed
25988068Eculizumab treatment for paroxysmal nocturnal haemoglobinuria in a patient with recurrent simultaneous multivessel coronary stent thrombosis.Oxf Med Case Reports2015https://conductscience.org/library/papers/25988068PubMed
24227693A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.Cytometry B Clin Cytom2014https://conductscience.org/library/papers/24227693PubMed
23617322Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.Br J Haematol2013https://conductscience.org/library/papers/23617322PubMed
23221988On the dynamics of neutral mutations in a mathematical model for a homogeneous stem cell population.J R Soc Interface2013https://conductscience.org/library/papers/23221988PubMed

See all 22 cited byDownload CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20011245

GET https://conductscience.org/api/papers/v1/20011245/references?page=2